Obesity-associated NLRC4 inflammasome activation drives breast cancer progression
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Obesity is associated with an increased risk of developing breast cancer and is also associated with worse clinical prognosis. The mechanistic link between obesity and breast cancer progression remains unclear, and there has been no development of specific treatments to improve the outcome of obese cancer patients. Here we show that obesity-associated NLRC4 inflammasome activation/ interleukin (IL)-1 signalling promotes breast cancer progression. The tumour microenvironment in the context of obesity induces an increase in tumour-infiltrating myeloid cells with an activated NLRC4 inflammasome that in turn activates IL-1β, which drives disease progression through adipocyte-mediated vascular endothelial growth factor A (VEGFA) expression and angiogenesis. Further studies show that treatment of mice with metformin inhibits obesity-associated tumour progression associated with a marked decrease in angiogenesis. This report provides a causal mechanism by which obesity promotes breast cancer progression and lays out a foundation to block NLRC4 inflammasome activation or IL-1β signalling transduction that may be useful for the treatment of obese cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In those cases, IL-1β is the key player, acting as pro-inflammatory, tumor-promoting trigger [126,127,128,129,130].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [129]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zaafar, D. K., Zaitone, S. A., & Moustafa, Y. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100562 · Cited by 74 · cited 1×
“This is consistent with previous studies that have shown that metformin lowers serum VEGFA levels in both human and mouse 39,40 .”
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Whether obesity has an impact on these diseases through enhancement of inflammation or via a direct mechanism is largely unclear; however, obese adipose tissue is a reservoir for macrophages with activated inflammasomes that contribute to insulin resistance and diabetes 10,11 .”
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“Metformin is known to have pleiotropic effects, and is thought to primarily work by inhibiting mitochondrial respiratory-chain complex-I, which leads to activation of adenosine monophosphate-activated protein kinase 38 .”
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · cited 1×
“We We did observe a significant increase in the number of tumour-infiltrating macrophages (F4/80 þ CD11b þ ); in particular, there was a significant increase in CD11c (cid:2) macrophages and a trend for increased CD11c þ macrophages 21 (Fig.”
Györffy, B., Lanczky, A., Eklund, A. C., Denkert, C., Budczies, J., Li, Q., & Szallasi, Z. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0674-9 · Cited by 4,169 · cited 2×
“In addition, KMPlot (http://kmplot.com/analysis/) was used to analyse microarray data sets that were normalized and combined for survival analysis 41 .”
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Metformin, a type 2 diabetes drug, reduces the risk of several types of cancer including breast cancer 35–37 .”
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Cited by
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Diverging inflammasome signals in tumorigenesis and potential targeting
Karki, R., & Kanneganti, T.-D. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0123-y · Cited by 641
The role of interleukin-1 in general pathology
Kaneko, N., Kurata, M., Yamamoto, T., Morikawa, S., & Masumoto, J. (2019) · Inflammation and Regeneration · doi:10.1186/s41232-019-0101-5 · Cited by 617
“A recent report showed that IL-1β orchestrates tumor-promoting inflammation in patients with high-risk HER2-negative breast cancer who would benefit from IL-1-blocking therapeutics with anakinra (described later on).”
BackgroundGut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
The obese adipose tissue microenvironment in cancer development and progression
Quail, D. F., & Dannenberg, A. J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0126-x · Cited by 542
Nutrition, inflammation and cancer
Zitvogel, L., Pietrocola, F., & Kroemer, G. (2017) · Nature Immunology · doi:10.1038/ni.3754 · Cited by 446
NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes
Freeman, L., Guo, H., David, C. N., Brickey, W. J., Jha, S., & Ting, J. P.-Y. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20150237 · Cited by 397
Karki, R., Man, S. M., & Kanneganti, T.-D. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0269 · Cited by 377
Rébé, C., & Ghiringhelli, F. (2020) · Cancers · doi:10.3390/cancers12071791 · Cited by 337
Lower Airway Dysbiosis Affects Lung Cancer Progression
Tsay, J.-C. J., Wu, B. G., Sulaiman, I., Gershner, K., Schluger, R., Li, Y., Yie, T.-A., Meyn, P., Olsen, E., Perez, L., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0263 · Cited by 322
“cancer models (breast cancer, gastric carcinoma, and lung cancer), inflammasome activation, 440 through IL-1β signaling, leads to an inflammatory response characterized by decreased anti441 tumor immune surveillance(47-49).”
BackgroundMolecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity
Hou, J., Hsu, J.-M., & Hung, M.-C. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.003 · Cited by 301
Inflammation-Induced Tumorigenesis and Metastasis
Hibino, S., Kawazoe, T., Kasahara, H., Itoh, S., Ishimoto, T., Sakata-Yanagimoto, M., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115421 · Cited by 290
Obesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 256
Harnessing innate immune pathways for therapeutic advancement in cancer
Hu, A., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 255
Obesity and aging: Molecular mechanisms and therapeutic approaches
Santos, A. L., & Sinha, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101268 · Cited by 230
Incio, J., Ligibel, J. A., McManus, D. T., Suboj, P., Jung, K., Kawaguchi, K., Pinter, M., Babykutty, S., Chin, S. M., Vardam, T. D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aag0945 · Cited by 222
Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms
Andò, S., Gelsomino, L., Panza, S., Giordano, C., Bonofiglio, D., Barone, I., & Catalano, S. (2019) · Cancers · doi:10.3390/cancers11010062 · Cited by 212
“proposed a novel molecular link between obesity and breast cancer involving NLRC4 inflammasome/IL-1β pathway activation in macrophages and the consequent increased angiogenesis through an up-regulation of vascular endothelial growth factor A (VEGFA) in adipocytes [117].”
BackgroundDmitrieva-Posocco, O., Dzutsev, A., Posocco, D. F., Hou, V., Yuan, W., Thovarai, V., Mufazalov, I. A., Gunzer, M., Shilovskiy, I. P., Khaitov, M. R., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.11.015 · Cited by 188
“, 2015), and environmental and dietary factors can drive inflammasome/IL-1 dependent breast cancer (Kolb et al., 2016).”
NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer
Faria, S. S., Costantini, S., de Lima, V. C. C., de Andrade, V. P., Rialland, M., Cedric, R., Budillon, A., & Magalhães, K. G. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00724-8 · Cited by 186
“Moreover, the analysis of The Cancer Genome Atlas (TCGA) dataset showed that CASP1 expression was increased in basal and luminal B type tumors of patients with obesity, whereas there is no correlation between obesity and CASP1 expression in HER2 or Luminal A subtypes breast cancer [76].”
BackgroundMethodMolecular mechanisms of inflammasome signaling
Mathur, A., Hayward, J. A., & Man, S. M. (2018) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0617-250r · Cited by 185
Tariq, M., Zhang, J., Liang, G., Ding, L., He, Q., & Yang, B. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25895 · Cited by 178
“Preclinical studies have revealed that metformin, an AMPK agonist, inhibits the recruitment of macrophages, mRNA expression level of IL-6 and angiogenesis in the obesity-associated tumor [Macci o andMadeddu, 2011; Kolb et al., 2016].”
BackgroundNOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies
Liu, P., Lu, Z., Liu, L., Li, R., Liang, Z., Shen, M., Xu, H., Ren, D., Ji, M., Yuan, S., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152925 · Cited by 173
Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis
Koh, E. H., Yoon, J. E., Ko, M. S., Leem, J., Yun, J.-Y., Hong, C. H., Cho, Y. K., Lee, S. E., Jang, J. E., Baek, J. Y., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322509 · Cited by 154
“14 15 Yet, the specific role of NLRC4 inflammasome in NASH remains largely unknown.”
A brain in flame; do inflammasomes and pyroptosis influence stroke pathology?
Barrington, J., Lemarchand, E., & Allan, S. M. (2017) · Brain Pathology · doi:10.1111/bpa.12476 · Cited by 165
“Interestingly, NLRC4 does not respond to necrotic cell death (45) but its role in sterile inflammation is becoming increasingly apparent, with reported links to acute coronary syndrome (47), breast cancer progression and diabetic nephropathy (53, 99).”
BackgroundWu, T.-C., Xu, K., Martinek, J., Young, R. R., Banchereau, R., George, J., Turner, J., Kim, K. I., Zurawski, S., Wang, X., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0413 · Cited by 165
Inflammation in cancer: therapeutic opportunities from new insights
Xie, Y., Liu, F., Wu, Y., Zhu, Y., Jiang, Y., Wu, Q., Dong, Z., & Liu, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02243-8 · Cited by 167
Context-dependent functions of pattern recognition receptors in cancer
Man, S. M., & Jenkins, B. J. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00462-5 · Cited by 151
Advances in Understanding Activation and Function of the NLRC4 Inflammasome
Sundaram, B., & Kanneganti, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031048 · Cited by 144
NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma
Wang, H., Luo, Q., Feng, X., Zhang, R., Li, J., & Chen, F. (2018) · BMC Cancer · doi:10.1186/s12885-018-4403-9 · Cited by 145
Ahechu, P., Zozaya, G., Martí, P., Hernández-Lizoáin, J. L., Baixauli, J., Unamuno, X., Frühbeck, G., & Catalán, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02918 · Cited by 143
“A causal mechanism by which obesity promotes the progression of breast cancer via the NLRC4 inflammasome activation has been recently described (187) but no results showing the impact of NLRP3 in obesity-associated CRC have been reported.”
BackgroundNOD-like receptors: major players (and targets) in the interface between innate immunity and cancer
Velloso, F. J., Trombetta-Lima, M., Anschau, V., Sogayar, M. C., & Correa, R. G. (2019) · Bioscience Reports · doi:10.1042/bsr20181709 · Cited by 134
Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
Kantono, M., & Guo, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01132 · Cited by 133
Regulation of CD8+ T cells by lipid metabolism in cancer progression
Tang, Y., Chen, Z., Zuo, Q., & Kang, Y. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01224-z · Cited by 135
Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4
Kolb, R., Kluz, P., Tan, Z. W., Borcherding, N., Bormann, N., Vishwakarma, A., Balcziak, L., Zhu, P., Davies, B. S., Gourronc, F., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0592-6 · Cited by 123
Self-citationChu, D., Nguyen, T. T. P., Tien, N. L. B., Khoa, T. D., Nguyen, T.-T., Thanh, V. V., Quang, T. L., Bui, L. M., Pham, V.-H., Ngọc, V. T. N., et al. (2019) · Cells · doi:10.3390/cells8080857 · Cited by 133
Insights into the Link Between Obesity and Cancer
Ackerman, S. E., Blackburn, O. A., Marchildon, F., & Cohen, P. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0263-x · Cited by 132
Sun, J., Chen, F., & Wu, G. (2023) · The ISME Journal · doi:10.1038/s41396-023-01483-0 · Cited by 127
Obesity and breast cancer: A case of inflamed adipose tissue
Kolb, R., & Zhang, W. (2020) · Cancers · doi:10.3390/cancers12061686 · Cited by 119
Self-citationThe NAIP/NLRC4 inflammasome in infection and pathology
Bauer, R., & Rauch, I. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100863 · Cited by 115
NOD‐like receptor C4 Inflammasome Regulates the Growth of Colon Cancer Liver Metastasis in NAFLD
Ohashi, K., Wang, Z., Yang, Y. M., Billet, S., Tu, W., Pimienta, M., Cassel, S. L., Pandol, S. J., Lu, S. C.-L., Sutterwala, F. S., et al. (2019) · Hepatology · doi:10.1002/hep.30693 · Cited by 115
“The generation of NLRC4-/- mice and NLRC4-Flag knock-in mice were described.(34,35) All mice were bred in the Cedars-Sinai Medical Center vivarium.”
BackgroundMethodResultInfluentialSelf-citationDubey, S. R., Turnbull, C., Pandey, A., Zhao, A., Kurera, M., Al-Zidan, R. N., Shen, C. X., Gautam, M., Mahajan, S., Jadhav, P. S., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01354-y · Cited by 115
Unveiling the link between chronic inflammation and cancer
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100347 · Cited by 109
Cancer-associated adipocytes as immunomodulators in cancer
Wu, Q., Li, B., Li, J., Sun, S., Yuan, J., & Sun, S. (2021) · Biomarker Research · doi:10.1186/s40364-020-00257-6 · Cited by 105
Linkage Between Obesity Leptin and Breast Cancer
Atoum, M. F. M., Alzoughool, F., & Al-Hourani, H. (2020) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223419898458 · Cited by 113
Obesity and the tumor microenvironment
Olson, O. C., Quail, D. F., & Joyce, J. A. (2017) · Science · doi:10.1126/science.aao5801 · Cited by 99
IL-1 Signaling in Tumor Microenvironment
Zhang, W., Borcherding, N. C., & Kolb, R. H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38315-2_1 · Cited by 107
Self-citationAdipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
Wu, B., Sun, X., Gupta, H. B., Yuan, B., Li, J., Ge, F., Chiang, H.-C., Zhang, X., Zhang, C., Zhang, D., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1500107 · Cited by 102
“and interleukin (IL)-1β promote tumor angiogenesis and recruitment of immunosuppressive neutrophils to the tumor microenvironment, respectively.(37,38) Given the impact of”
BackgroundMolecular Links between Central Obesity and Breast Cancer
Zimța, A., Țigu, A. B., Muntean, M. V., Cenariu, D., Slaby, O., & Berindan‐Neagoe, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215364 · Cited by 107
Obesity diminishes response to PD-1-based immunotherapies in renal cancer
Boi, S. K., Orlandella, R. M., Gibson, J. T., Turbitt, W. J., Wald, G., Thomas, L., Buchta Rosean, C., Norris, K. E., Bing, M., Bertrand, L., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000725 · Cited by 94
“However, given the uncertainty in the field, rigorous continued study of this critical issue is needed to better inform patient care.”
Kay, C., Wang, R., Kirkby, M., & Man, S. M. (2020) · Immunological Reviews · doi:10.1111/imr.12906 · Cited by 97
Obesity promotes the expansion of metastasis-initiating cells in breast cancer
Bousquenaud, M., Fico, F., Solinas, G., Rüegg, C., & Santamaria‐Martínez, A. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1029-4 · Cited by 102
How Comorbidities Shape Cancer Biology and Survival
Panigrahi, G., & Ambs, S. (2021) · Trends in cancer · doi:10.1016/j.trecan.2020.12.010 · Cited by 97
Inflammasome: structure, biological functions, and therapeutic targets
Dai, Y., Zhou, J., & Shi, C. (2023) · MedComm · doi:10.1002/mco2.391 · Cited by 98
Zhang, Y., Fang, C., Zhang, W., & Zhang, K. (2022) · Matter · doi:10.1016/j.matt.2022.08.026 · Cited by 89
Self-citationDivergent functions of NLRP3 inflammasomes in cancer: a review
Shadab, A., Mahjoor, M., Abbasi‐Kolli, M., Afkhami, H., Moeinian, P., & Safdarian, A.-R. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01235-9 · Cited by 87
“In the TCGA breast cancer dataset, NLRP3 had a positive correlation with survival in all molecular subtypes [68].”
BackgroundGibson, J. T., Orlandella, R. M., Turbitt, W. J., Behring, M. P., Manne, U., Sorge, R. E., & Norian, L. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590794 · Cited by 88
Involvement of inflammasomes in tumor microenvironment and tumor therapies
Zhang, Z., Li, X., Wang, Y., Wei, Y., & Wei, X. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01407-7 · Cited by 88
“Additionally, this pathway has also been reported in adipocytes [168].”
BackgroundInfluentialDynamic roles of inflammasomes in inflammatory tumor microenvironment
Jang, J., Kim, D., & Surh, Y. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00154-7 · Cited by 86
Obesity: a perfect storm for carcinogenesis
Harris, B. H. L., Macaulay, V. M., Harris, D. A., Klenerman, P., Karpe, F., Lord, S., Harris, A. L., & Buffa, F. M. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10046-2 · Cited by 88
“Also tumour-infiltrating myeloid cells showed an activated NLRC4 inflammasome in breast cancer mouse models and these can lead to crosstalk with adipocytes to promote angiogenesis and disease progression [228].”
BackgroundEkambaram, P., Lee, J.-Y. L., Hubel, N. E., Hu, D. G., Yerneni, S. S., Campbell, P. G., Pollock, N., Klei, L. R., Concel, V. J., Delekta, P. C., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1089 · Cited by 83
Inflammasome inhibitors: promising therapeutic approaches against cancer
Xu, S., Li, X., Liu, Y., Xia, Y., Chang, R., & Zhang, C. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0755-0 · Cited by 86
Self-citationRole of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks
Lin, T.-Y., Tsai, M.-C., Tu, W., Yeh, H., Wang, S., Huang, S., & Li, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610492 · Cited by 80
Hyperglycemia-induced inflamm-aging accelerates gingival senescence via NLRC4 phosphorylation
Zhang, P., Wang, Q., Nie, L., Zhu, R., Zhou, X., Zhao, P., Ji, N., Liang, X., Ding, Y., Yuan, Q., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010648 · Cited by 70
“We suggest that NLRC4 phosphorylation could be promoted by a hyperglycemia-associated protein with homologous function to the known NLRC4-activating bacterial components (23, 47).”
BackgroundCellular mechanisms linking cancers to obesity
Liu, X., Pedersen, L., & Halberg, N. (2021) · Cell Stress · doi:10.15698/cst2021.05.248 · Cited by 78
“The NLRC4/IL-1β module was able to promote angiogenesis via up-regulation of VEGFA, which in turn to contributed tumor progression [108].”
BackgroundUpdating the NLRC4 Inflammasome: from Bacterial Infections to Autoimmunity and Cancer
Wen, J., Xuan, B., Liu, Y., Wang, L., He, L., Meng, X., Zhou, T., & Wang, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702527 · Cited by 78
Self-citationLeptin: A Heavyweight Player in Obesity-Related Cancers
Caruso, A., Gelsomino, L., Panza, S., Accattatis, F. M., Naimo, G. D., Barone, I., Giordano, C., Catalano, S., & Andò, S. (2023) · Biomolecules · doi:10.3390/biom13071084 · Cited by 74
mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus
Li, X., Zhang, B., Pan, Y., Shi, G., Ren, J., Fan, H., Dou, H., & Hou, Y. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy088 · Cited by 75
Metabolic regulation of inflammasomes in inflammation
Yang, Q., Liu, R., Yu, Q., Bi, Y., & Liu, G. (2019) · Immunology · doi:10.1111/imm.13056 · Cited by 74
(2022) · doi:10.1016/j.hsr.2021.100010 · Cited by 69
Desmedt, C., Demicheli, R., Fornili, M., Bachir, I., Duca, M., Viglietti, G., Berlière, M., Piccart, M. J., Sotiriou, C. P., Sosnowski, M., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy042 · Cited by 72
Inflammasome as a promising therapeutic target for cancer
Lee, C., Do, H. T. T., Her, J., Kim, Y., Seo, D., & Rhee, I. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116593 · Cited by 69
Raut, P. K., Kim, S., Choi, D. Y., Jeong, G., & Park, P. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.006 · Cited by 68
Tenthorey, J. L., Chavez, R. A., Thompson, T. W., Deets, K. A., Vance, R. E., & Rauch, I. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191736 · Cited by 67
Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer
Maharjan, C. K., Mo, J., Wang, L. A., Kim, M., Wang, S., Borcherding, N. C., Vikas, P., & Zhang, W. (2021) · Cancers · doi:10.3390/cancers14010206 · Cited by 76
“Inflammation is a key feature associated with obese adipose tissue [70,71] and could be one of the important contributors to obesity-associated estrogen production.”
BackgroundSelf-citationOmental adipocytes promote peritoneal metastasis of gastric cancer through the CXCL2–VEGFA axis
Natsume, M., Shimura, T., Iwasaki, H., Okuda, Y., Hayashi, K., Takahashi, S., & Kataoka, H. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0898-3 · Cited by 67
Paudel, S., Ghimire, L., Jin, L., Baral, P., Cai, S., & Jeyaseelan, S. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0088-2 · Cited by 65
Wu, X., Qian, S., Zhang, J., Feng, J., Luo, K., Sun, L., Zhao, L., Ran, Y., Sun, L., Wang, J., et al. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00260-x · Cited by 67
The microbiome and cytosolic innate immune receptors
Liwinski, T., Zheng, D., & Elinav, E. (2020) · Immunological Reviews · doi:10.1111/imr.12901 · Cited by 65
Turbitt, W. J., Rosean, C. B., Weber, K. S., & Norian, L. A. (2020) · Immunological Reviews · doi:10.1111/imr.12849 · Cited by 62
Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin
Gao, Y., Chen, X., He, Q. W., Gimple, R. C., Liao, Y., Wang, L., Wu, R., Xie, Q., Rich, J. N., Shen, K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005950117 · Cited by 62
Self-citationBreast cancer microenvironment and obesity: challenges for therapy
Hillers‐Ziemer, L. E., Kuziel, G. M., Williams, A. E., Moore, B. N., & Arendt, L. M. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10031-9 · Cited by 62
“In mammary tumorbearing obese mice, metformin treatment reduced obesityassociated tumor growth and was associated with a marked decrease in angiogenesis within the tumor microenvironment [229].”
BackgroundThe role of pyroptosis in modulating the tumor immune microenvironment
Wu, J., Wang, L., & Xu, J. (2022) · Biomarker Research · doi:10.1186/s40364-022-00391-3 · Cited by 55
The roles of inflammasomes in cancer
Deng, Z., Lu, L., Li, B., Shi, X., Jin, H., & Hu, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1195572 · Cited by 55
Interfering Role of ERα on Adiponectin Action in Breast Cancer
Naimo, G. D., Gelsomino, L., Catalano, S., Mauro, L., & Andò, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00066 · Cited by 55
Pham, D., & Park, P. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01274-7 · Cited by 57
Jin, H., Ko, G. H., & Kim, H. J. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4552 · Cited by 51
“In addition, inflammasome-modulated IL-1 signaling induces the suppression of anticancer immune responses in natural killer (NK) cells and T cells, which is disadvantageous for the progression and development of fibrocarcinoma, gastric cancer, melanoma and breast cancer (46-49).”
Obesity and pancreatic cancer: An update of epidemiological evidence and molecular mechanisms
Zhou, B., Wu, D., Liu, H., Du, L., Wang, Y., Xu, J., Qiu, F., Hu, S., & Zhan, H. (2019) · Pancreatology · doi:10.1016/j.pan.2019.08.008 · Cited by 54
Pham, D., Raut, P. K., Pandit, M., Chang, J., Katila, N., Choi, D., Jeong, J., & Park, P. (2020) · Cancers · doi:10.3390/cancers12030613 · Cited by 53
“Likewise, increased expression of NLRC4 was found in tumor tissues from obese breast cancer patients and NLRC4 inflammasome is required for obesity-driven breast-cancer progression in diet-induced obese mice [22].”
BackgroundRecurrence dynamics of breast cancer according to baseline body mass index
Biganzoli, E. M., Desmedt, C., Fornili, M., de Azambuja, E., Cornez, N., Ries, F., Closon-Dejardin, M. T., Kerger, J. N., Focan, C., Leo, A. D., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.10.007 · Cited by 54
Gan, H. K., Zhang, L., Chen, H., Xiao, H., Wang, L., Zhai, X., Jiang, N., Liang, P., Zheng, S., & Zhao, J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00702-y · Cited by 50
Aquaporin-7 Regulates the Response to Cellular Stress in Breast Cancer
Dai, C., Charlestin, V., Wang, M., Walker, Z. T., Miranda-Vergara, M. C., Facchine, B. A., Wu, J., Kaliney, W. J., Dovic̀hi, N. J., Li, J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2269 · Cited by 51
Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients
Lim, J., Kim, M. J., Park, Y., Ahn, J. W., Hwang, S., Moon, J., Cho, K. G., & Kwack, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-44261-9 · Cited by 48
NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway
Zhong, C., Wang, R., Hua, M., Zhang, C., Han, F., Xu, M., Yang, X., Li, G., Hu, X., Sun, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661939 · Cited by 56
Conner, S. J., Borges, H. B., Guarin, J. R., Gerton, T. J., Yui, A., Salhany, K. J., Mensah, D. N., Hamilton, G. A., Le, G. H., Lew, K. C., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2526 · Cited by 47
Interplay between dendritic cells and cancer cells
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.07.008 · Cited by 44
Metformin coordinates osteoblast/osteoclast differentiation associated with ischemic osteonecrosis
Park, S., Kang, M., Moon, Y. J., Jang, K. Y., & Kim, J. R. (2020) · Aging · doi:10.18632/aging.102796 · Cited by 46
Yuan, C., Liu, C., Wang, T., He, Y., Zhou, Z., Dun, Y., Zhao, H., Ren, D., Wang, J., Zhang, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16052 · Cited by 45
RetractedNLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer
Sonnessa, M., Cioffi, A., Brunetti, O., Silvestris, N., Zito, F. A., Saponaro, C., & Mangia, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01587 · Cited by 44
Jin, H., & Kim, H. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093337 · Cited by 41
“The NLRC4 inflammasome mediates the expression of adipocyte-mediated vascular endothelial growth factor A and angiogenesis, which accelerates the progression of breast cancer [22].”
BackgroundAdipose tissue-to-breast cancer crosstalk: Comprehensive insights
Wu, Y., Li, X., Li, Q., Cheng, C., & Zheng, L. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188800 · Cited by 43
Metadata
- Authors
- Kolb, R., Phan, L., Borcherding, N., Liu, Y., Yuan, F., Janowski, A. M., Xie, Q., Markan, K. R., Li, W., Potthoff, M. J., Fuentes-Mattei, E., Ellies, L. G., Knudson, C. M., Lee, M.-H., Yeung, S.-C. J., Cassel, S. L., Sutterwala, F. S., & Zhang, W.
- Affiliations
- University of Iowa (US)
- The University of Texas MD Anderson Cancer Center (US)
- Central South University (CN)
- University of California San Diego (US)
- Corresponding author
- Zhang, Weizhou
- ORCID
- Venue
- Nature Communications
- Published
- 2016-10-06
- Volume
- 7
- Issue
- 1
- Pages
- 13007-13007
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5059727
- OpenAlex
- W2529393815
- Cited by
- 239
- References
- 58
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 17 · 2023: 34 · 2022: 27 · 2021: 37 · 2020: 39 · 2019: 24 · 2018: 17 · 2017: 14 · 2016: 2
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (NIH T32, KG081048, NIH-R01, AI118719, CA158055)
- University of Texas Health Science Center at San Antonio
- Holden Comprehensive Cancer Center, University of Iowa (P30-CA086862)
- National Cancer Institute (K99CA158055, CA203834, R00CA158055, R01CA200673, CA200673, L30 CA199587, R01CA203834, K22CA118182, P30CA086862)
- National Institute of Allergy and Infectious Diseases (R56AI118719, T32AI007260, R01AI104706, T32AI007485, T32AI007517)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK111758)
- National Institute on Minority Health and Health Disparities (L60 MD006355)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- obesity, breast cancer progression, NLRC4 inflammasome, tumor microenvironment, VEGF-A, angiogenesis, adipocytes, metformin
- MeSH terms
- Animals, Breast, Breast Neoplasms, Calcium-Binding Proteins, Female, Humans, Mammary Neoplasms, Experimental, Mice, Inbred C57BL, Neoplasm Transplantation, Obesity, Signal Transduction, Lymphocytes, Tumor-Infiltrating, Disease Progression, Myeloid Cells, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.